Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This review is part of the PlexusDx Education Hub, our resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables behind every metabolic decision. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx holds no commercial relationship with Medvi or its parent company, and no affiliate links or compensation are involved.

A "Medvi GLP-1" search usually wants the full picture of the program’s offering: which GLP-1 medications it dispenses, who qualifies, and how prescribing is handled. This editorial review lays out Medvi’s menu, its eligibility path, and its pricing structure as visible on the brand’s own site. Fair-balance framing, not a buying recommendation, as of April 2026.

What Medvi’s GLP-1 menu includes

Medvi (Medvi Wellness) operates as a telehealth and compounded-pharmacy program. Its current menu, verified July 2026, is compounded semaglutide injection, compounded tirzepatide injection, and a dissolvable GLP-1 tablet taken once daily, alongside branded Wegovy and Zepbound options routed through a separate membership. A licensed provider reviews a virtual intake and, where appropriate, issues a prescription filled through a licensed 503A compounding pharmacy. See MEDVi’s official website for the current lineup.

How eligibility and prescribing work

Access follows a familiar telehealth sequence: you complete an intake covering weight, medical history, and current medications; a licensed clinician reviews it and, if eligibility is met, issues a prescription; the prescription routes to a licensed compounding pharmacy (or, for branded products, a retail pharmacy); and follow-up supports dose titration and side-effect management. Provider type, pharmacy partner, and subscription structure vary within this model.

Pricing across the plans

On MEDVi’s compounded plans the ongoing rate is $299 per month for semaglutide and $399 per month for tirzepatide, each with a lower first-month promotional price ($159 for semaglutide, $259 for tirzepatide, verified July 2026). Prepaid multi-month plans lower the effective monthly cost — MEDVi’s 3-month semaglutide plan is $475 (about $158 per month), and its 12-month tirzepatide plan is $2,859 (about $238 per month). The compounded plans carry no membership fee; the branded Wegovy and Zepbound routes use a separate $99 membership plus medication cost, and the dissolvable tablet’s price is shown after intake. Verify current pricing at MEDVi’s official website — numbers change over time.

What the research shows on GLP-1 receptor agonists

The offering’s pharmacology comes from the compound class itself: GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide). The anchor trials are STEP (semaglutide for weight management, The New England Journal of Medicine, 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Trial populations and endpoints differ, and outcomes vary individually.

The layer the menu leaves out

A GLP-1 menu tells you which compound you can get, not how your body is wired to respond to it. Variants in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene that every GLP-1 compound targets), MC4R (a melanocortin receptor central to satiety), and TCF7L2 (a transcription factor tied to glucose homeostasis and GLP-1 secretion) map the metabolic terrain any compound works on. Pathway-level and not predictive of a specific compound’s effect, they are the context a medication menu never captures.

PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. What extends the menu is the context that precedes it. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — the FTO, GLP1R, MC4R, and TCF7L2 variants shaping your baseline appetite, energy-balance, and GLP-1 biology. Reading that alongside the protocol is the test before you invest approach, turning guesswork into an informed provider conversation.

Not affiliated: PlexusDx is not affiliated with Medvi and has no commercial relationship with the companies reviewed in this article.

Related reading on PlexusDx: What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist, GLP 1 Drugs.

Disclaimer: This article is educational. PlexusDx is not affiliated with Medvi and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare the PlexusDx approach: see the Weight Management Protocols — semaglutide and tirzepatide with the genetic context most telehealth programs skip. Or start upstream: take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.

Frequently Asked Questions

Which GLP-1 medications does Medvi offer?

As verified July 2026, Medvi’s menu includes compounded semaglutide injection, compounded tirzepatide injection, and a once-daily dissolvable GLP-1 tablet, plus branded Wegovy and Zepbound routed through a separate membership. The compounded products come from licensed 503A pharmacies. Confirm the current lineup on Medvi’s own site before deciding.

How do I qualify for Medvi’s GLP-1 program?

You complete a virtual intake covering weight, medical history, and medications, and a licensed clinician determines eligibility before issuing any prescription. If eligible, the prescription routes to a compounding pharmacy or, for branded products, a retail pharmacy, with follow-up for titration. There is no guaranteed prescription ahead of clinical review.

What does Medvi’s GLP-1 program cost?

Ongoing compounded rates are about $299 per month for semaglutide and $399 for tirzepatide, each with a lower first month ($159 and $259). Prepaid plans reduce the effective monthly cost — a 3-month semaglutide plan at $475 and a 12-month tirzepatide plan at $2,859, verified July 2026. Branded routes add a $99 membership.

Does the Precision Peptide Genetic Test predict which GLP-1 will work for me?

No. It does not predict response to any specific compound or program. It analyzes pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that shape baseline GLP-1 biology — upstream context that informs your conversation with a provider regardless of which GLP-1 medication is prescribed.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves